1 - 25 of 32 results for author:"Clark-Lewis I." in Literature citations
Results Customize
› Repeat search in UniProtKB (22)
| Inhibition of CCR6 function reduces the severity of experimental autoimmune encephalomyelitis via effects on the priming phase of the immune response. Liston A., Kohler R.E., Townley S., Haylock-Jacobs S., Comerford I., Caon A.C., Webster J., Harrison J.M., Swann J., Clark-Lewis I. et al. J. Immunol. 182:3121-3130(2009) · Mapped (4) |
| Antagonism of the chemokine receptors CXCR3 and CXCR4 reduces the pathology of experimental autoimmune encephalomyelitis. Kohler R.E., Comerford I., Townley S., Haylock-Jacobs S., Clark-Lewis I., McColl S.R. Brain Pathol. 18:504-516(2008) · Mapped (2) |
| The CC chemokine ligand, CCL2/MCP1, participates in macrophage fusion and foreign body giant cell formation. Kyriakides T.R., Foster M.J., Keeney G.E., Tsai A., Giachelli C.M., Clark-Lewis I., Rollins B.J., Bornstein P. Am. J. Pathol. 165:2157-2166(2004) · Mapped (5) |
| NMR structure of CXCR3 binding chemokine CXCL11 (ITAC). Booth V., Clark-Lewis I., Sykes B.D. Protein Sci. 13:2022-2028(2004) · UniProtKB (1) |
| HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Zhang K., McQuibban G.A., Silva C., Butler G.S., Johnston J.B., Holden J., Clark-Lewis I., Overall C.M., Power C. Nat. Neurosci. 6:1064-1071(2003) · Mapped (2) |
| A role for macrophage inflammatory protein-3 alpha/CC chemokine ligand 20 in immune priming during T cell-mediated inflammation of the central nervous system. Kohler R.E., Caon A.C., Willenborg D.O., Clark-Lewis I., McColl S.R. J. Immunol. 170:6298-6306(2003) · Mapped (3) |
| Eotaxin-3 is a natural antagonist for CCR2 and exerts a repulsive effect on human monocytes. Ogilvie P., Paoletti S., Clark-Lewis I., Uguccioni M. Blood 102:789-794(2003) · Mapped (1) |
| Cathepsin D specifically cleaves the chemokines macrophage inflammatory protein-1 alpha, macrophage inflammatory protein-1 beta, and SLC that are expressed in human breast cancer. Wolf M., Clark-Lewis I., Buri C., Langen H., Lis M., Mazzucchelli L. Am. J. Pathol. 162:1183-1190(2003) · Mapped (8) |
| The CXCR3 binding chemokine IP-10/CXCL10: structure and receptor interactions. Booth V., Keizer D.W., Kamphuis M.B., Clark-Lewis I., Sykes B.D. Biochemistry 41:10418-10425(2002) · UniProtKB (1) |
| Structure/function of human herpesvirus-8 MIP-II (1-71) and the antagonist N-terminal segment (1-10). Crump M.P., Elisseeva E., Gong J., Clark-Lewis I., Sykes B.D. FEBS Lett. 489:171-175(2001) · Mapped (1) |
| Human CC chemokine I-309, structural consequences of the additional disulfide bond. Keizer D.W., Crump M.P., Lee T.W., Slupsky C.M., Clark-Lewis I., Sykes B.D. Biochemistry 39:6053-6059(2000) · UniProtKB (1) |
| Identification of the orphan receptor G-protein-coupled receptor 2 as CCR10, a specific receptor for the chemokine ESkine. Jarmin D.I., Rits M., Bota D., Gerard N.P., Graham G.J., Clark-Lewis I., Gerard C. J. Immunol. 164:3460-3464(2000) · UniProtKB (2) |
| ESkine, a novel beta-chemokine, is differentially spliced to produce secretable and nuclear targeted isoforms. Baird J.W., Nibbs R.J.B., Komai-Koma M., Connolly J.A., Ottersbach K., Clark-Lewis I., Liew F.Y., Graham G.J. J. Biol. Chem. 274:33496-33503(1999) · UniProtKB (1) |
| Solution structure of eotaxin, a chemokine that selectively recruits eosinophils in allergic inflammation. Crump M.P., Rajarathnam K., Kim K.S., Clark-Lewis I., Sykes B.D. J. Biol. Chem. 273:22471-22479(1998) · UniProtKB (1) |
| B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. Legler D.F., Loetscher M., Stuber Roos R., Clark-Lewis I., Baggiolini M., Moser B. |
| Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. Crump M.P., Gong J.H., Loetscher P., Rajarathnam K., Amara A., Arenzana-Seisdedos F., Virelizier J.-L., Baggiolini M., Sykes B.D., Clark-Lewis I. EMBO J. 16:6996-7007(1997) · UniProtKB (1) |
| Characterisation of macrophage inflammatory protein-5/human CC cytokine-2, a member of the macrophage-inflammatory-protein family of chemokines. Coulin F., Power C.A., Alouani S., Peitsch M.C., Schroeder J.M., Moshizuki M., Clark-Lewis I., Wells T.N. Eur. J. Biochem. 248:507-515(1997) |
| An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model. Gong J.H., Ratkay L.G., Waterfield J.D., Clark-Lewis I. J. Exp. Med. 186:131-137(1997) · Mapped (3) |
| The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Graham K.A., Lalani A.S., Macen J.L., Ness T.L., Barry M., Liu L.Y., Lucas A., Clark-Lewis I., Moyer R.W., McFadden G. Virology 229:12-24(1997) · UniProtKB (2) |
| Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. Loetscher M., Gerber B., Loetscher P., Jones S.A., Piali L., Clark-Lewis I., Baggiolini M., Moser B. J. Exp. Med. 184:963-969(1996) · UniProtKB (1) |
| Structural characterization of a monomeric chemokine: monocyte chemoattractant protein-3. Kim K.-S., Rajarathnam K., Clark-Lewis I., Sykes B.D. FEBS Lett. 395:277-282(1996) · UniProtKB (3) |
| The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Oberlin E., Amara A., Bachelerie F., Bessia C., Virelizier J.-L., Arenzana-Seisdedos F., Schwartz O., Heard J.-M., Clark-Lewis I., Legler D.F. et al. Nature 382:833-835(1996) · UniProtKB (2) |
| The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Bleul C.C., Farzan M., Choe H., Parolin C., Clark-Lewis I., Sodroski J., Springer T.A. Nature 382:829-833(1996) · UniProtKB (1) |
| RANTES and MCP-3 antagonists bind multiple chemokine receptors. Gong J.H., Uguccioni M., Dewald B., Baggiolini M., Clark-Lewis I. J. Biol. Chem. 271:10521-10527(1996) |
| Deletion of the NH2-terminal residue converts monocyte chemotactic protein 1 from an activator of basophil mediator release to an eosinophil chemoattractant. Weber M., Uguccioni M., Baggiolini M., Clark-Lewis I., Dahinden C.A. J. Exp. Med. 183:681-685(1996) · UniProtKB (1) |